In the US, Etretinate is a member of the drug class antipsoriatics.
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
D05BB01
CAS registry number (Chemical Abstracts Service)
0054350-48-0
Chemical Formula
C23-H30-O3
Molecular Weight
354
Therapeutic Category
Dermatological agent: Antipsoriatic
Chemical Name
2,4,6,8-Nonatetraenoic acid, 9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-, ethyl ester, (all-E)-
Foreign Names
- Etretinatum (Latin)
- Etretinat (German)
- Etrétinate (French)
- Etretinato (Spanish)
Generic Names
- Etretinate (OS: USAN, JAN, BAN)
- Étrétinate (OS: DCF)
- Etretinato (OS: DCIT)
- Ro 10-9359 (IS)
- Ro 10-9359-9 (IS)
Brand Name
- Tigason
Chugai, Japan
International Drug Name Search
Glossary
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment